177 related articles for article (PubMed ID: 19766516)
1. Cerebral folate deficiency and CNS inflammatory markers in Alpers disease.
Hasselmann O; Blau N; Ramaekers VT; Quadros EV; Sequeira JM; Weissert M
Mol Genet Metab; 2010 Jan; 99(1):58-61. PubMed ID: 19766516
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits.
Ramaekers VT; Blau N; Sequeira JM; Nassogne MC; Quadros EV
Neuropediatrics; 2007 Dec; 38(6):276-81. PubMed ID: 18461502
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome.
Ramaekers VT; Rothenberg SP; Sequeira JM; Opladen T; Blau N; Quadros EV; Selhub J
N Engl J Med; 2005 May; 352(19):1985-91. PubMed ID: 15888699
[TBL] [Abstract][Full Text] [Related]
4. POLG1 mutations associated with progressive encephalopathy in childhood.
Kollberg G; Moslemi AR; Darin N; Nennesmo I; Bjarnadottir I; Uvebrant P; Holme E; Melberg A; Tulinius M; Oldfors A
J Neuropathol Exp Neurol; 2006 Aug; 65(8):758-68. PubMed ID: 16896309
[TBL] [Abstract][Full Text] [Related]
5. Reduced folate transport to the CNS in female Rett patients.
Ramaekers VT; Hansen SI; Holm J; Opladen T; Senderek J; Häusler M; Heimann G; Fowler B; Maiwald R; Blau N
Neurology; 2003 Aug; 61(4):506-15. PubMed ID: 12939425
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of Alpers syndrome.
Nguyen KV; Sharief FS; Chan SS; Copeland WC; Naviaux RK
J Hepatol; 2006 Jul; 45(1):108-16. PubMed ID: 16545482
[TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI.
Brunetti-Pierri N; Selby K; O'Sullivan M; Hendson G; Truong C; Waters PJ; Wong LJ
Neuropediatrics; 2008 Jun; 39(3):179-83. PubMed ID: 18991199
[TBL] [Abstract][Full Text] [Related]
8. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.
Naviaux RK; Nguyen KV
Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711
[TBL] [Abstract][Full Text] [Related]
9. Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome.
Chan SS; Longley MJ; Naviaux RK; Copeland WC
DNA Repair (Amst); 2005 Dec; 4(12):1381-9. PubMed ID: 16181814
[TBL] [Abstract][Full Text] [Related]
10. POLG mutations in Alpers syndrome.
Nguyen KV; Østergaard E; Ravn SH; Balslev T; Danielsen ER; Vardag A; McKiernan PJ; Gray G; Naviaux RK
Neurology; 2005 Nov; 65(9):1493-5. PubMed ID: 16177225
[TBL] [Abstract][Full Text] [Related]
11. Cerebral folate deficiency.
Ramaekers VT; Blau N
Dev Med Child Neurol; 2004 Dec; 46(12):843-51. PubMed ID: 15581159
[TBL] [Abstract][Full Text] [Related]
12. Polymerase gamma deficiency (POLG): clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh's encephalopathy.
Scalais E; Francois B; Schlesser P; Stevens R; Nuttin C; Martin JJ; Van Coster R; Seneca S; Roels F; Van Goethem G; Löfgren A; De Meirleir L
Eur J Paediatr Neurol; 2012 Sep; 16(5):542-8. PubMed ID: 22342071
[TBL] [Abstract][Full Text] [Related]
13. POLG mutations and Alpers syndrome.
Davidzon G; Mancuso M; Ferraris S; Quinzii C; Hirano M; Peters HL; Kirby D; Thorburn DR; DiMauro S
Ann Neurol; 2005 Jun; 57(6):921-3. PubMed ID: 15929042
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome.
Ramaekers VT; Sequeira JM; Artuch R; Blau N; Temudo T; Ormazabal A; Pineda M; Aracil A; Roelens F; Laccone F; Quadros EV
Neuropediatrics; 2007 Aug; 38(4):179-83. PubMed ID: 18058624
[TBL] [Abstract][Full Text] [Related]
15. A novel POLG gene mutation in 4 children with Alpers-like hepatocerebral syndromes.
Kurt B; Jaeken J; Van Hove J; Lagae L; Löfgren A; Everman DB; Jayakar P; Naini A; Wierenga KJ; Van Goethem G; Copeland WC; DiMauro S
Arch Neurol; 2010 Feb; 67(2):239-44. PubMed ID: 20142534
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the neuronal vulnerability underpinning Alpers' syndrome: a clinical and neuropathological study.
Hayhurst H; Anagnostou ME; Bogle HJ; Grady JP; Taylor RW; Bindoff LA; McFarland R; Turnbull DM; Lax NZ
Brain Pathol; 2019 Jan; 29(1):97-113. PubMed ID: 30021052
[TBL] [Abstract][Full Text] [Related]
17. Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome.
Schaller A; Hahn D; Jackson CB; Kern I; Chardot C; Belli DC; Gallati S; Nuoffer JM
BMC Neurol; 2011 Jan; 11():4. PubMed ID: 21235791
[TBL] [Abstract][Full Text] [Related]
18. Alpers syndrome with mutations in POLG: clinical and investigative features.
Hunter MF; Peters H; Salemi R; Thorburn D; Mackay MT
Pediatr Neurol; 2011 Nov; 45(5):311-8. PubMed ID: 22000311
[TBL] [Abstract][Full Text] [Related]
19. Application of oligonucleotide array CGH in the detection of a large intragenic deletion in POLG associated with Alpers Syndrome.
Compton AG; Troedson C; Wilson M; Procopis PG; Li FY; Brundage EK; Yamazaki T; Thorburn DR; Wong LJ
Mitochondrion; 2011 Jan; 11(1):104-7. PubMed ID: 20708716
[TBL] [Abstract][Full Text] [Related]
20. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease.
Cardenas JF; Amato RS
Semin Pediatr Neurol; 2010 Mar; 17(1):62-4. PubMed ID: 20434700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
